CRL
Charles River Laboratories International, Inc.
Stock
$290.19+3.36 (+1.17%)Close Oct 2, 2026
- Capital expenditures, 2025
- $219M
- YoY, 2025
- −5.9%
- 5-year CAGR
- +5.6%
- 10-year CAGR
- +13.2%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $219M | −5.9% |
| 2024 | $233M | −26.9% |
| 2023 | $319M | −1.9% |
| 2022 | $325M | +41.9% |
| 2021 | $229M | +37.4% |
| 2020 | $167M | +18.5% |
| 2019 | $141M | +0.3% |
| 2018 | $140M | +69.9% |
| 2017 | $82M | +49.1% |
| 2016 | $55M | −12.6% |
| 2015 | $63M | +11.1% |
| 2014 | $57M | +45.4% |
| 2013 | $39M | −17.6% |
| 2012 | $48M | −3.3% |
| 2011 | $49M | +14.7% |
| 2010 | $43M | −46.3% |
| 2009 | $80M | −59.8% |
| 2008 | $199M | — |